Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$18.53 - $51.61
Next Earnings Date
May 08 2025
Next Earnings Date
May 08 2025
Latest price
Market Cap | $1.42B |
EV | $838.45M |
Shares Outstanding | 65.52M |
Beta | 1.28 |
Analyst Rating | BUY |
Analyst Target Price | $64.23 |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | - |
EPS | -4.20% |
Operating Cash Flow | -78.40% |
Free Cash Flow | -78.90% |
Revenue | - |
EPS | 0.90% |
Operating Cash Flow | -16.20% |
Free Cash Flow | 7.50% |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | -39.21% |
ROCE 2024 | -44.83% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Vera Therapeutics, Inc.
VERA
Sector
Healthcare
Industry
Biotechnology
CEO
Fordyce, Marshall
Employees
112
Website
veratx.comIPO Date
2021-05-14
Headquarters
8000 Marina Boulevard, Suite 120, Brisbane, California, 94005, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved